Muthusamy Shanmugam - Aug 14, 2025 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
HEAD OF R&D, COO-NOVITIUM OPS, Director
Signature
/s/ Muthusamy Shanmugam, by attorney-in-fact Meredith W. Cook
Stock symbol
ANIP
Transactions as of
Aug 14, 2025
Transactions value $
-$8,824,533
Form type
4
Date filed
8/18/2025, 04:32 PM
Previous filing
May 13, 2025
Next filing
Aug 22, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS, Director C/O ANI PHARMACEUTICALS, INC., 210 MAIN STREET WEST, BAUDETTE /s/ Muthusamy Shanmugam, by attorney-in-fact Meredith W. Cook 2025-08-18 0001870913

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Sale -$4.21M -47K -7.44% $89.48 585K Aug 14, 2025 Held by Esjay LLC F1, F2
transaction ANIP Common Stock Sale -$4.62M -53K -9.06% $87.15 532K Aug 15, 2025 Held by Esjay LLC F2, F3
holding ANIP Common Stock 92.6K Aug 14, 2025 Direct
holding ANIP Common Stock 5K Aug 14, 2025 Held by SS Pharma LLC F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold in multiple trades at prices ranging from $88.20 to $90.11. The price reported above reflects the weighted average sales price.
F2 The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
F3 The shares were sold in multiple trades at prices ranging from $85.44 to $90.00. The price reported above reflects the weighted average sales price.
F4 The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.